Menu
close
Please contact us for more information or to learn if you are eligible to participate.
To evaluate the effectiveness of repurposed medications [(study drug(s)] in reducing symptoms of nonhospitalized participants with mild to moderate COVID-19
Principal Investigator | Sohail Rao, MD |
Co-PI | Luis Cantu Jr. |
Sponsor | National Center for Advancing Translation Sciences |
Type of Trial | Interventional |